Stay updated on Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A new revision tag (v3.5.4) has been added to the record history, and the previous revision tag (v3.5.3) has been removed from the history.
    Difference
    0.1%
    Check dated 2026-05-14T23:16:26.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.2 to v3.5.3 in the page history, signaling a new build of the page. This change reflects an internal update to the page version and does not affect study data or visible content.
    Difference
    0.1%
    Check dated 2026-04-30T16:47:47.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added a new revision entry v3.5.2 to the history and removed the earlier v3.5.0 entry.
    Difference
    0.1%
    Check dated 2026-04-16T10:23:46.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed in the Record History.
    Difference
    0.1%
    Check dated 2026-03-18T17:43:55.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry v3.4.3 and removes the previous revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:46:33.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    The study record now shows a Completed status with updated Study Status and Recruitment Status, and new References and Contacts/Locations sections have been added. The previous government-funding operating status notice has been removed.
    Difference
    1.0%
    Check dated 2026-02-11T02:13:29.000Z thumbnail image

Stay in the know with updates to Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.